Our results of the MetS subjects are in accordance with cross-sectional studies in which low levels of testosterone and SHBG have been associated with metabolic syndrome or its components including abdominal obesity, insulin resistance or hyperinsulinemia, dyslipidemia, and impaired glucose metabolism [27–29]. The gene discussed is SHBG; the disease is Insulin resistance.